Cargando…
Acute Exacerbation of COPD
Acute exacerbations of COPD involve increased symptoms such as cough, dyspnea and sputum production. These exacerbations are associated with increased mortality as well as decline in lung function. Non-invasive positive-pressure ventilation (NIPPV) is the preferred method of ventilatory support in r...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7121203/ http://dx.doi.org/10.1007/978-3-030-26710-0_22 |
_version_ | 1783515150189330432 |
---|---|
author | Lief, Lindsay McSparron, Jakob |
author_facet | Lief, Lindsay McSparron, Jakob |
author_sort | Lief, Lindsay |
collection | PubMed |
description | Acute exacerbations of COPD involve increased symptoms such as cough, dyspnea and sputum production. These exacerbations are associated with increased mortality as well as decline in lung function. Non-invasive positive-pressure ventilation (NIPPV) is the preferred method of ventilatory support in respiratory failure secondary to AECOPD. NIPPV reduces work of breathing, improves oxygenation and ventilation and decreases both mortality and the risk of invasive ventilation. Other therapies for AECOPD include inhaled bronchodilators and systemic glucocorticoids. Antibiotics are recommended for severe exacerbations. Future areas of interest in treatment for AECOPD include utilization of biomarkers and extracorporeal carbon dioxide removal. |
format | Online Article Text |
id | pubmed-7121203 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
record_format | MEDLINE/PubMed |
spelling | pubmed-71212032020-04-06 Acute Exacerbation of COPD Lief, Lindsay McSparron, Jakob Evidence-Based Critical Care Article Acute exacerbations of COPD involve increased symptoms such as cough, dyspnea and sputum production. These exacerbations are associated with increased mortality as well as decline in lung function. Non-invasive positive-pressure ventilation (NIPPV) is the preferred method of ventilatory support in respiratory failure secondary to AECOPD. NIPPV reduces work of breathing, improves oxygenation and ventilation and decreases both mortality and the risk of invasive ventilation. Other therapies for AECOPD include inhaled bronchodilators and systemic glucocorticoids. Antibiotics are recommended for severe exacerbations. Future areas of interest in treatment for AECOPD include utilization of biomarkers and extracorporeal carbon dioxide removal. 2019-07-24 /pmc/articles/PMC7121203/ http://dx.doi.org/10.1007/978-3-030-26710-0_22 Text en © Springer Nature Switzerland AG 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Article Lief, Lindsay McSparron, Jakob Acute Exacerbation of COPD |
title | Acute Exacerbation of COPD |
title_full | Acute Exacerbation of COPD |
title_fullStr | Acute Exacerbation of COPD |
title_full_unstemmed | Acute Exacerbation of COPD |
title_short | Acute Exacerbation of COPD |
title_sort | acute exacerbation of copd |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7121203/ http://dx.doi.org/10.1007/978-3-030-26710-0_22 |
work_keys_str_mv | AT lieflindsay acuteexacerbationofcopd AT mcsparronjakob acuteexacerbationofcopd |